Skip Header

Contribute Send feedback
Read comments (?) or add your own

Q9Y6K0 (CEPT1_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 86. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (3) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Choline/ethanolaminephosphotransferase 1

Short name=hCEPT1
EC=2.7.8.1
EC=2.7.8.2
Gene names
Name:CEPT1
ORF Names:PRO1101
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length416 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Catalyzes both phosphatidylcholine and phosphatidylethanolamine biosynthesis from CDP-choline and CDP-ethanolamine, respectively. Involved in protein-dependent process of phospholipid transport to distribute phosphatidyl choline to the lumenal surface. Has a higher cholinephosphotransferase activity than ethanolaminephosphotransferase activity. Ref.1 Ref.6

Catalytic activity

CDP-ethanolamine + 1,2-diacylglycerol = CMP + a phosphatidylethanolamine. Ref.1

CDP-choline + 1,2-diacylglycerol = CMP + a phosphatidylcholine. Ref.1

Cofactor

Magnesium or manganese. Ref.1

Pathway

Phospholipid metabolism; phosphatidylethanolamine biosynthesis; phosphatidylethanolamine from ethanolamine: step 3/3.

Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphatidylcholine from phosphocholine: step 2/2.

Subcellular location

Endoplasmic reticulum membrane; Multi-pass membrane protein. Nucleus membrane; Multi-pass membrane protein Ref.8.

Tissue specificity

Ubiquitously expressed. Ref.1

Sequence similarities

Belongs to the CDP-alcohol phosphatidyltransferase class-I family.

Biophysicochemical properties

Kinetic parameters:

KM=37 µM for CDP-choline Ref.1 Ref.7

KM=101 µM for CDP-ethanolamine

Vmax=10.5 nmol/min/mg enzyme with CDP-choline as substrate

Vmax=4.35 nmol/min/mg enzyme with CDP-ethanolamine as substrate

Sequence caution

The sequence AAF61194.1 differs from that shown. Reason: Frameshift at position 276.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 416416Choline/ethanolaminephosphotransferase 1
PRO_0000289245

Regions

Transmembrane87 – 10721Helical; Potential
Transmembrane115 – 13521Helical; Potential
Transmembrane186 – 20621Helical; Potential
Transmembrane209 – 22921Helical; Potential
Transmembrane239 – 25921Helical; Potential
Transmembrane283 – 30321Helical; Potential
Transmembrane317 – 33721Helical; Potential
Transmembrane365 – 38521Helical; Potential

Amino acid modifications

Modified residue181Phosphoserine Ref.9
Modified residue401Phosphothreonine Ref.9
Glycosylation1441N-linked (GlcNAc...) Potential

Experimental info

Mutagenesis1381K → M: Induces a reduction in both cholinephosphotransferase and ethanolaminephosphotransferase activities.
Mutagenesis1441N → G: No effect. Ref.8
Mutagenesis1461S → Q or C: No effect. Ref.8
Mutagenesis1561G → C, S or A: Induces a reduction in cholinephosphotransferase activity and abolishes ethanolaminephosphotransferase activity. Ref.8
Mutagenesis2141T → A: Alters the profile of diacylglycerol utilization and results in modest reduction in enzyme activity. Ref.8
Mutagenesis2151E → A or D: Induces a strong reduction in enzyme activity without altering diacylglycerol specificity. Ref.8
Mutagenesis2151E → Q: Induces a strong reduction in enzyme activity and alters diacylglycerol specificity. Ref.8
Mutagenesis2161V → A: Alters the profile of diacylglycerol utilization and results in modest reduction in enzyme activity. Ref.8
Mutagenesis2211I → A: Alters the profile of diacylglycerol utilization and results in modest reduction in enzyme activity. Ref.8
Mutagenesis2261L → A: Does not affect either the enzyme activity or the diacylglycerol specificity. Ref.8
Mutagenesis2281V → A: Does not affect either the enzyme activity or the diacylglycerol specificity. Ref.8

Sequences

Sequence LengthMass (Da)Tools
Q9Y6K0 [UniParc].

Last modified November 1, 1999. Version 1.
Checksum: A25FED1193342FD9

FASTA41646,554
        10         20         30         40         50         60 
MSGHRSTRKR CGDSHPESPV GFGHMSTTGC VLNKLFQLPT PPLSRHQLKR LEEHRYQSAG 

        70         80         90        100        110        120 
RSLLEPLMQG YWEWLVRRVP SWIAPNLITI IGLSINICTT ILLVFYCPTA TEQAPLWAYI 

       130        140        150        160        170        180 
ACACGLFIYQ SLDAIDGKQA RRTNSSSPLG ELFDHGCDSL STVFVVLGTC IAVQLGTNPD 

       190        200        210        220        230        240 
WMFFCCFAGT FMFYCAHWQT YVSGTLRFGI IDVTEVQIFI IIMHLLAVIG GPPFWQSMIP 

       250        260        270        280        290        300 
VLNIQMKIFP ALCTVAGTIF SCTNYFRVIF TGGVGKNGST IAGTSVLSPF LHIGSVITLA 

       310        320        330        340        350        360 
AMIYKKSAVQ LFEKHPCLYI LTFGFVSAKI TNKLVVAHMT KSEMHLHDTA FIGPALLFLD 

       370        380        390        400        410 
QYFNSFIDEY IVLWIALVFS FFDLIRYCVS VCNQIASHLH IHVFRIKVST AHSNHH 

« Hide

References

« Hide 'large scale' references
[1]"Cloning and expression of a human choline/ethanolaminephosphotransferase: synthesis of phosphatidylcholine and phosphatidylethanolamine."
Henneberry A.L., McMaster C.R.
Biochem. J. 339:291-298(1999) [PubMed: 10191259] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, TISSUE SPECIFICITY.
[2]"Functional prediction of the coding sequences of 5 new genes deduced by analysis of cDNA clones from human fetal liver."
Zhang C., Yu Y., Zhang S., Zhou G., Wei H., Bi J., Xu W., Zai Y., Feng F., Liu M., He F.
Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Fetal liver.
[3]"The DNA sequence and biological annotation of human chromosome 1."
Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. expand/collapse author list , Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.
Nature 441:315-321(2006) [PubMed: 16710414] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[4]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Lymph and Pancreas.
[5]"The full-ORF clone resource of the German cDNA consortium."
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I.
BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-162.
Tissue: Bone marrow.
[6]"Cloning, genomic organization, and characterization of a human cholinephosphotransferase."
Henneberry A.L., Wistow G., McMaster C.R.
J. Biol. Chem. 275:29808-29815(2000) [PubMed: 10893425] [Abstract]
Cited for: FUNCTION.
[7]"PC and PE synthesis: mixed micellar analysis of the cholinephosphotransferase and ethanolaminephosphotransferase activities of human choline/ethanolamine phosphotransferase 1 (CEPT1)."
Wright M.M., McMaster C.R.
Lipids 37:663-672(2002) [PubMed: 12216837] [Abstract]
Cited for: BIOPHYSICOCHEMICAL PROPERTIES.
[8]"The major sites of cellular phospholipid synthesis and molecular determinants of fatty acid and lipid head group specificity."
Henneberry A.L., Wright M.M., McMaster C.R.
Mol. Biol. Cell 13:3148-3161(2002) [PubMed: 12221122] [Abstract]
Cited for: SUBCELLULAR LOCATION, MUTAGENESIS OF ASN-144; SER-146; GLY-156; THR-214; GLU-215; VAL-216; ILE-221; LEU-226 AND VAL-228.
[9]"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M.
Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND THR-40, MASS SPECTROMETRY.
Tissue: Cervix carcinoma.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AF068302 mRNA. Translation: AAD25170.1.
AF138862 mRNA. Translation: AAF61194.1. Frameshift.
AL355816 Genomic DNA. Translation: CAI19367.1.
BC032610 mRNA. Translation: AAH32610.1.
BC049196 mRNA. Translation: AAH49196.1.
AL833102 mRNA. Translation: CAH10403.1.
IPIIPI00005775.
RefSeqNP_001007795.1. NM_001007794.1.
NP_006081.1. NM_006090.3.
UniGeneHs.363572.
Hs.636850.

3D structure databases

ProteinModelPortalQ9Y6K0.
ModBaseSearch...

Protein-protein interaction databases

IntActQ9Y6K0. 2 interactions.
STRINGQ9Y6K0.

PTM databases

PhosphoSiteQ9Y6K0.

Polymorphism databases

DMDM74753524.

Proteomic databases

PRIDEQ9Y6K0.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000357172; ENSP00000349696; ENSG00000134255.
GeneID10390.
KEGGhsa:10390.
UCSCuc001eah.1. human.

Organism-specific databases

CTD10390.
GeneCardsGC01P111682.
H-InvDBHIX0000871.
HGNCHGNC:24289. CEPT1.
neXtProtNX_Q9Y6K0.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG16251.
GeneTreeENSGT00530000063048.
HOGENOMHBG386512.
HOVERGENHBG107647.
InParanoidQ9Y6K0.
OMACCFAGMF.
OrthoDBEOG4V6ZGJ.
PhylomeDBQ9Y6K0.

Gene expression databases

ArrayExpressQ9Y6K0.
BgeeQ9Y6K0.
CleanExHS_CEPT1.
GenevestigatorQ9Y6K0.

Family and domain databases

InterProIPR000462. CDP-OH_P_trans.
IPR014472. CHOPT.
[Graphical view]
KOK13644.
PfamPF01066. CDP-OH_P_transf. 1 hit.
[Graphical view]
PIRSFPIRSF015665. CHOPT. 1 hit.
PROSITEPS00379. CDP_ALCOHOL_P_TRANSF. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

DrugBankDB00122. Choline.
NextBio39360.

Entry information

Entry nameCEPT1_HUMAN
AccessionPrimary (citable) accession number: Q9Y6K0
Secondary accession number(s): Q69YJ9, Q9P0Y8
Entry history
Integrated into UniProtKB/Swiss-Prot: May 29, 2007
Last sequence update: November 1, 1999
Last modified: January 25, 2012
This is version 86 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 1

Human chromosome 1: entries, gene names and cross-references to MIM

PATHWAY comments

Index of metabolic and biosynthesis pathways

SIMILARITY comments

Index of protein domains and families